Syn2bio (WAR:S2B) Other Operating Expense: zł Mil (TTM As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:S2B Syn2bio SA WAR:S2B
9 GF Score
Price zł64.00
! 1 Warning Sign
View Full Analysis

What is Syn2bio Other Operating Expense?

Syn2bio WAR:S2B -0.44% 9 Other Operating Expense is zł Mil as of Sep. 2025. GuruFocus rates WAR:S2B with a GF Score™ of 9/100. The stock has 1 warning sign investors should review.

Syn2bio's Other Operating Expense for the six months ended in Sep. 2025 was zł-0.03 Mil. Syn2bio does not have enough years/quarters to calculate its Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2025.

Syn2bio's quarterly Other Operating Expense increased from Sep. 2023 (zł-0.05 Mil) to Sep. 2024 (zł-0.03 Mil) but then declined from Sep. 2024 (zł-0.03 Mil) to Sep. 2025 (zł-0.03 Mil).

Syn2bio's annual Other Operating Expense increased from Sep. 2023 (zł-0.05 Mil) to Sep. 2024 (zł-0.03 Mil) but then declined from Sep. 2024 (zł-0.03 Mil) to Sep. 2025 (zł-0.03 Mil).

Syn2bio Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Syn2bio's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Syn2bio Other Operating Expense Chart

Syn2bio Annual Data
Trend Sep23 Sep24 Sep25
Other Operating Expense
-0.05 -0.03 -0.03

Syn2bio Semi-Annual Data
Sep23 Sep24 Sep25
Other Operating Expense -0.05 -0.03 -0.03
WAR:S2B
9GF Score
Syn2bio SA WAR:S2B
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Syn2bio Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of zł Mil mean?
Syn2bio (WAR:S2B) has a Other Operating Expense of zł Mil as of Sep. 2025. Other operating expenses that a company records on its income statement. View historical data on Syn2bio and its competitors.
Is Syn2bio's Other Operating Expense too high?
Syn2bio's current Other Operating Expense is zł Mil. Overall, Syn2bio has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Syn2bio's Other Operating Expense compare to VRTX and REGN?
Syn2bio's Other Operating Expense of zł Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Biotechnology company?
A good Other Operating Expense depends on the Biotechnology industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Syn2bio and its competitors. Syn2bio's current Other Operating Expense is zł Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Syn2bio stock overvalued right now?
Syn2bio (WAR:S2B) has a current Other Operating Expense of zł Mil. The current Other Operating Expense is zł Mil. Syn2bio's overall GF Score™ is 9/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Syn2bio (WAR:S2B), the current Other Operating Expense is zł Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Syn2bio Business Description

Address ul. Jozefa Piusa Dziekonskiego 3, Warszawa, POL, 00-728
Syn2bio SA is a Polish biotech company that develops radiopharmaceuticals. It specializes in developing a cardiac biomarker for diagnosing heart conditions like coronary artery disease through myocardial perfusion imaging. The company's flagship product is the SYN2 cardiotracer. It is applied in the detection of perfusion disorders, evaluation of patients after myocardial infarction or with ischemic heart disease, and assessment of atherosclerotic changes in coronary arteries.
9GF Score

Get the complete analysis for WAR:S2B

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł64.00
Price